First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers

This publication has 15 references indexed in Scilit:

• Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854 902 patients
  Prenatal Diagnosis, 2002
• One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies
  Ultrasound in Obstetrics & Gynecology, 2002
• Combined ultrasound and biochemical screening for Down's Syndrome in the first trimester: a Scottish multicentre study
  BJOG: An International Journal of Obstetrics and Gynaecology, 2002
• Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study
  The Lancet, 2001
• Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland
  European Journal of Human Genetics, 2001
• Integrating antenatal Downʼs syndrome screening
  Current Opinion in Obstetrics and Gynecology, 2001
• Letter. Correct estimation of parameters for ultrasound nuchal translucency screening
  Prenatal Diagnosis, 1998
• REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTS
  Prenatal Diagnosis, 1996
• Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
  BJOG: An International Journal of Obstetrics and Gynaecology, 1975